4:50 PM ET
8-K
Other 8-K Filing
Genvor Other 8-K Filing
Genvor Incorporated entered into an Intellectual Property Assignment Agreement with its founder and Chief Scientific Officer, Dr. Jesse Jaynes. Dr. Jaynes assigned the rights to approximately 9,000 synthetic antimicrobial peptide sequences and associated validation data to the company for use in its research and commercialization programs.
- Counterparty
- Dr. Jesse Jaynes